D. Goren et al., Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump, CLIN CANC R, 6(5), 2000, pp. 1949-1957
Folic acid, attached to polyethyleneglycol-derivatized, distearoyl-phosphat
idylethanolamine, was used to target irt vitro liposomes to folate receptor
(FR)-overexpressing tumor cells, Confocal fluorescence microscopic observa
tions demonstrated binding and subsequent internalization of rhodamine-labe
led liposomes by a high FR-expressing, murine lung carcinoma line (M109-HiF
R cells), with inhibition by free folic acid. Additional experiments tracki
ng doxorubicin (DOX) fluorescence with DOS-loaded, folate-targeted liposome
s (FTLs) indicate that liposomal DOX is rapidly internalized, released in t
he cytoplasmic compartment, and, shortly thereafter, detected in the nucleu
s, the entire process lasting 1-2 h, FR-mediated cell uptake of targeted Li
posomal DOX into a multidrug-resistant subline of M109-HiFR cells (M109R-Hi
FR) was unaffected by P-glycoprotein-mediated drug efflux, in sharp contras
t to uptake of free DOX, based on verapamil-blockade experiments with quant
itation of cell-associated DOX and flow cytometry analysis, Delivery of DOX
by FTLs to M109R-HiFR cells increased continuously with time of exposure,
reaching higher drug concentrations in whole cells and nuclei compared with
exposure to free DOS. The ill vitro cytotoxic activity obtained with DOX-l
oaded FTLs was 10-fold greater than that of the nontargeted liposome formul
ation, but was not improved over that of free DOX despite the higher cellul
ar drug levels obtained with the targeted liposomes in M109R-HiFR cells. Ho
wever, if M109R-HiFR cells were exposed to drugs in vitro and tested in an
in vivo adoptive assay for tumor growth in syngeneic mice along a 5-week ti
me span, FTL DOX was significantly more tumor inhibitory than free DOT. It
is suggested that the biological activity of liposomal DOX released inside
the cellular compartment is reduced in vitro due to the aggregated state of
DOX, resulting from the liposome drug-loading process, and requires a long
period of time and/or an irt vivo environment for full expression.